Form 4: Apyx Medical Director Receives Stock Option Grant

Director Minnie Baylor-Henry was granted 50,000 stock options in Apyx Medical Corp as part of a standard equity incentive.

Summary

• Director Minnie Baylor-Henry received a grant of 50,000 stock options for Apyx Medical Corp common stock.
• The options have an exercise price of $4.65 per share.
• The grant date is June 11, 2026, with an expiration date of June 11, 2036.
• The options vest ratably over a 12-month period, becoming fully exercisable on the first anniversary of the grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Aligns director interests with long-term shareholder value through equity-based compensation.

Negatives

• Results in potential future dilution of existing shareholders upon exercise of the options.

Risks

• Market price volatility may impact the future value of the granted options.
• The value of the options is contingent upon the company's stock performance exceeding the $4.65 strike price.

Future Outlook

The options vest over a one-year period, indicating a commitment to the company's performance through at least June 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-executive directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests in the medical device sector.

Comparison to Industry Standards

• The 12-month vesting schedule is consistent with standard director compensation packages for small-cap medical technology firms.
• The grant size is typical for independent director annual equity retainers.

Stakeholder Impact

• Minor potential dilution for existing shareholders if options are exercised.

Next Steps

• Vesting of options on a monthly basis over the next 12 months.
• Full exercisability of options on June 11, 2027.

Key Dates

Keywords

Apyx Medical, APYX, Form 4, Insider Trading, Stock Options, Director Compensation